agilon health (NYSE:AGL – Get Rating) had its price objective increased by Guggenheim from $21.00 to $30.00 in a research report report published on Monday morning, The Fly reports. The brokerage currently has a buy rating on the stock.
A number of other equities analysts also recently issued reports on the company. Wells Fargo & Company cut their target price on agilon health from $28.00 to $22.00 and set an overweight rating for the company in a research note on Tuesday, November 15th. The Goldman Sachs Group dropped their price objective on agilon health from $38.00 to $34.00 and set a buy rating for the company in a research note on Tuesday, November 15th. Stifel Nicolaus initiated coverage on agilon health in a research note on Thursday, December 8th. They issued a buy rating and a $23.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on agilon health from $26.00 to $28.00 in a research note on Friday. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and an average target price of $28.63.
agilon health Stock Performance
Shares of AGL stock opened at $24.35 on Monday. The company has a market cap of $10.06 billion, a price-to-earnings ratio of -93.65 and a beta of 1.09. The stock has a 50 day simple moving average of $20.47 and a 200-day simple moving average of $20.22. agilon health has a 12-month low of $14.82 and a 12-month high of $28.36. The company has a current ratio of 2.71, a quick ratio of 2.71 and a debt-to-equity ratio of 0.04.
Insiders Place Their Bets
Institutional Investors Weigh In On agilon health
Several hedge funds have recently made changes to their positions in AGL. IFP Advisors Inc boosted its holdings in shares of agilon health by 236.3% during the third quarter. IFP Advisors Inc now owns 1,231 shares of the company’s stock worth $38,000 after purchasing an additional 865 shares during the last quarter. Van ECK Associates Corp boosted its holdings in agilon health by 41.5% in the fourth quarter. Van ECK Associates Corp now owns 2,738 shares of the company’s stock valued at $44,000 after acquiring an additional 803 shares during the last quarter. Lazard Asset Management LLC acquired a new position in agilon health in the first quarter valued at $69,000. Vigilant Capital Management LLC acquired a new position in agilon health in the third quarter valued at $102,000. Finally, Point72 Middle East FZE acquired a new position in agilon health in the fourth quarter valued at $111,000.
About agilon health
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
- Get a free copy of the StockNews.com research report on agilon health (AGL)
- Go Where the Money Is. Here’s 3 Top Bank Dividend Stocks to Buy
- Another Catalyst For Mullen Automotive Stock
- Solar Tech-Services; Nextracker Should Be On Your Radar
- Is American Lithium a Safe Bet as Demand for Lithium Soars
- Highwoods Properties, High-quality Real Estate for a Discount
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.